...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >N-linked glycosylation and its impact on the electrophoretic mobility and function of the human proton-coupled folate transporter (HsPCFT).
【24h】

N-linked glycosylation and its impact on the electrophoretic mobility and function of the human proton-coupled folate transporter (HsPCFT).

机译:N联糖基化及其对人类质子偶联叶酸转运蛋白(HsPCFT)的电泳迁移率和功能的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The human proton-coupled folate transporter (HsPCFT, SLC46A1) mediates intestinal absorption of folates and transport of folates into the liver, brain and other tissues. On Western blot, HsPCFT migrates as a broad band (~55 kDa), higher than predicted (~50 kDa) in cell lines. Western blot analysis required that membrane preparations not be incubated in the loading buffer above 50 degrees C to avoid aggregation of the protein. Treatment of membrane fractions from HsPCFT-transfected HeLa cells with peptidyl N-glycanase F, or cells with tunicamycin, resulted in conversion to a ~35 kDa species. Substitution of asparagine residues of two canonical glycosylation sites to glutamine, individually, yielded a ~47 kDa protein; substitution of both sites gave a smaller (~35 kDa) protein. Single mutants retained full transport activity; the double mutant retained a majority of activity. Transport function and molecular size were unchanged when the double mutant was hemagglutinin (HA) tagged at either the NH(2) or COOH terminus and probed with an anti-HA antibody excluding degradation of the deglycosylated protein. Wild-type or deglycosylated HsPCFT HA, tagged at amino or carboxyl termini, could only be visualized on the plasma membrane when HeLa cells were first permeabilized, consistent with the intracellular location of these domains.
机译:人质子偶联的叶酸转运蛋白(HsPCFT,SLC46A1)介导叶酸在肠道的吸收以及叶酸转运到肝脏,大脑和其他组织中。在Western印迹上,HsPCFT迁移为一条宽带(〜55 kDa),高于细胞系中的预期值(〜50 kDa)。 Western blot分析要求不要在高于50摄氏度的加样缓冲液中孵育膜制剂,以免蛋白质聚集。用肽基N-聚糖酶F处理HsPCFT转染的HeLa细胞或用衣霉素处理的细胞膜部分,可转化为约35 kDa的物种。两个典型的糖基化位点的天冬酰胺残基分别取代为谷氨酰胺,产生约47 kDa的蛋白质。两个位点的取代产生较小的蛋白质(〜35 kDa)。单个突变体保留了完整的转运活性。双突变体保留了大部分活性。当双突变体被血凝素(HA)标记在NH(2)或COOH末端并用抗HA抗体(不包括去糖基化蛋白的降解)进行探测时,运输功能和分子大小没有变化。标记在氨基或羧基末端的野生型或去糖基化的HsPCFT HA仅在首次渗透HeLa细胞时才能在质膜上看到,这与这些域的细胞内位置一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号